Balasa Dinverno & Foltz’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-547
| Closed | -$271K | – | 339 |
|
2022
Q2 | $271K | Sell |
547
-401
| -42% | -$199K | 0.02% | 284 |
|
2022
Q1 | $534K | Sell |
948
-326
| -26% | -$184K | 0.04% | 188 |
|
2021
Q4 | $963K | Buy |
1,274
+230
| +22% | +$174K | 0.06% | 133 |
|
2021
Q3 | $779K | Buy |
1,044
+48
| +5% | +$35.8K | 0.05% | 143 |
|
2021
Q2 | $642K | Sell |
996
-69
| -6% | -$44.5K | 0.05% | 161 |
|
2021
Q1 | $608K | Buy |
1,065
+38
| +4% | +$21.7K | 0.05% | 160 |
|
2020
Q4 | $599K | Buy |
1,027
+158
| +18% | +$92.2K | 0.05% | 151 |
|
2020
Q3 | $448K | Buy |
869
+205
| +31% | +$106K | 0.04% | 162 |
|
2020
Q2 | $300K | Buy |
+664
| New | +$300K | 0.03% | 174 |
|